(Lys9)GLP-1 possesses DPP IV resistance and cellular and metabolic actions similar to those of established antagonists GLP-1(9-36)amide and exendin(9-39).

F.P.M. O'Harte, Brian Green, Mark Mooney, V.A. Gault, N. Irwin, Patrick Harriott, B. Greer, P.R. Flatt

Research output: Contribution to journalMeeting abstractpeer-review

Original languageEnglish
Pages (from-to)P10
JournalIrish journal of medical science
Issue numberS1
Publication statusPublished - 2003

Cite this